HVTN 123: A Phase 1, Randomized Trial Comparing Safety and Immunogenicity of CH505TF gp120 Produced by Stably and Transiently Transfected Cell Lines is a research paper published in The Journal of Infectious Diseases (2024). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: UM1 AI068614
National Institutes of Health
Grant: UM1 AI068635
National Institutes of Health
Grant: UM1 AI068618
National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Disease
FWCI
0.00
Citation Percentile
0.2%
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals